24 /100
LOW RISK
Score updated Jul 13, 2026

BLFS — BioLife Solutions, Inc. Dilution Risk Tracker

Track BLFS dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track BLFS — Get alerts when the score changes →

As of July 13, 2026, BioLife Solutions, Inc. (BLFS) has a DilutionWatch DilutionScore of 24/100, rated LOW dilution risk. BioLife Solutions, Inc. has a market capitalization of $1.22B, 48.86M shares outstanding, 190 institutional holders tracked. Key dilution vectors include approximately 46 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
0
📊 Float Risk
10
⚠️ Warrant Exposure
40
🔄Convertible Debt—

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for BLFS.
🔔 Track BLFS — Get forecast alerts →

💹 Market Data

Market Cap$1.22B
Shares Outstanding48.86M
Float42.84M
Cash$22.82M
Debt$2.50M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 8.7% shares (2026Q1 vs prior)
190 institutional holders · 54.49M shares
#1 T. Rowe Price Investment Management, Inc. 6.51M shares
#2 BlackRock, Inc. 6.10M shares
#3 Casdin Capital, LLC 5.96M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest3.01M
Days to Cover2.0
% of Float7.0%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2023
xbrl XBRL CONVERTIBLE Dec 31, 2017
4 INSIDER TRANSACTION Apr 10, 2026
4 INSIDER TRANSACTION Apr 10, 2026
4 INSIDER TRANSACTION Apr 10, 2026
Full SEC filing analysis available with free account →

📰 Recent News

No recent news

📋 What This Means for BLFS Shareholders

BioLife Solutions, Inc. (BLFS) has a DilutionScore of 24/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 13, 2026.

DilutionWatch's EDGAR monitoring for BLFS shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for BLFS in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for BLFS alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track BLFS Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking BLFS — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

LBTYA LBTYK AER AIG BABA

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for BLFS
📊 BLFS FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 BLFS Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.